Insulin aspart, recombinant Subcutaneous and Topiramate Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Topiramate Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: topiramate
Brand name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Topiragen, Qudexy XR
Synonyms: Topiramate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Topiramate ER Capsules
- Insulin aspart, recombinant Subcutaneous-Topiramate Extended-Release Capsules
- Insulin aspart, recombinant Subcutaneous-Topiramate Extended-Release Sprinkle Capsules
- Insulin aspart, recombinant Subcutaneous-Topiramate Sprinkle Capsules
- Insulin aspart, recombinant Subcutaneous-Topiramate Tablets
- Insulin aspart, recombinant Subcutaneous-Topisulf Cream
- Topiramate Capsules-Insulin degludec
- Topiramate Capsules-Insulin Degludec (U-100) Prefilled Pens
- Topiramate Capsules-Insulin Degludec (U-100) Vials
- Topiramate Capsules-Insulin Degludec (U-200) Prefilled Pens
- Topiramate Capsules-Insulin degludec and liraglutide
- Topiramate Capsules-Insulin degludec and liraglutide Subcutaneous